{"transactions":[{"id":701341,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-07-30T01:33:55.000Z","date":"2026-07-27","kind":"grant","planned":false,"acquired":true,"shares":185798,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase 185,798 shares of the Issuer's common stock, one quarter of which will vest on July 27, 2027, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date."}],"balance_after":185798,"derivative":{"exercise_price":28.56,"expiration_date":"2036-07-27","underlying":"Common Stock","underlying_shares":185798},"source":{"system":"sec-edgar","filing":"0001104659-26-088370","document":"tm2621459-10_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000110465926088370/tm2621459-10_4seq1.xml","form_type":"4"}},{"id":703376,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-07-24T21:00:10.000Z","date":"2026-07-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":22516,"price":0.8976,"value":20210.3616,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":74918,"source":{"system":"sec-edgar","filing":"0001867033-26-000008","document":"form4-07242026_050707.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000186703326000008/form4-07242026_050707.xml","form_type":"4"}},{"id":717264,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-07-03T00:05:09.000Z","date":"2026-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":3464,"price":0.6507,"value":2254.0248,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":97434,"source":{"system":"sec-edgar","filing":"0001867033-26-000006","document":"form4-07022026_080706.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000186703326000006/form4-07022026_080706.xml","form_type":"4"}},{"id":818991,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-04-02T20:15:23.000Z","date":"2026-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":4007,"price":0.5975,"value":2394.1825,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":99788,"source":{"system":"sec-edgar","filing":"0001867033-26-000004","document":"form4-04022026_040408.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000186703326000004/form4-04022026_040408.xml","form_type":"4"}},{"id":950214,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2026-01-05T13:30:09.000Z","date":"2025-12-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":7858,"price":0.5801,"value":4558.4258,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":103795,"source":{"system":"sec-edgar","filing":"0001867033-26-000002","document":"form4-01052026_080105.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000186703326000002/form4-01052026_080105.xml","form_type":"4"}},{"id":1026542,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-10-02T21:05:10.000Z","date":"2025-09-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":3420,"price":0.335,"value":1145.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":111653,"source":{"system":"sec-edgar","filing":"0001867033-25-000003","document":"form4-10022025_051007.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000186703325000003/form4-10022025_051007.xml","form_type":"4"}},{"id":1094335,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-07-02T20:30:48.000Z","date":"2025-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":3420,"price":1.65,"value":5643.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":115073,"source":{"system":"sec-edgar","filing":"0001415889-25-019059","document":"form4-07022025_040710.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588925019059/form4-07022025_040710.xml","form_type":"4"}},{"id":1182659,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-04-02T20:15:24.000Z","date":"2025-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":8399,"price":1.58,"value":13270.42,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":118493,"source":{"system":"sec-edgar","filing":"0001415889-25-009633","document":"form4-04022025_040416.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588925009633/form4-04022025_040416.xml","form_type":"4"}},{"id":1296217,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Stock Option (right to buy)","published_at":"2025-01-23T21:15:13.000Z","date":"2025-01-21","kind":"grant","planned":false,"acquired":true,"shares":230000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on March 31, 2026 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":230000,"derivative":{"exercise_price":2.77,"expiration_date":"2035-01-20","underlying":"Common Stock","underlying_shares":230000},"source":{"system":"sec-edgar","filing":"0001415889-25-001927","document":"form4-01232025_040109.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588925001927/form4-01232025_040109.xml","form_type":"4"}},{"id":1318315,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2025-01-02T22:45:11.000Z","date":"2024-12-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":4675,"price":3.35,"value":15661.25,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":126892,"source":{"system":"sec-edgar","filing":"0001415889-25-000156","document":"form4-01022025_050107.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588925000156/form4-01022025_050107.xml","form_type":"4"}},{"id":1393749,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-10-02T20:15:16.000Z","date":"2024-09-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":84,"price":1.88,"value":157.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":131567,"source":{"system":"sec-edgar","filing":"0001415889-24-024383","document":"form4-10022024_041008.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588924024383/form4-10022024_041008.xml","form_type":"4"}},{"id":1459351,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-07-03T20:15:18.000Z","date":"2024-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":92,"price":1.92,"value":176.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":131651,"source":{"system":"sec-edgar","filing":"0001415889-24-019176","document":"form4-07032024_040715.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588924019176/form4-07032024_040715.xml","form_type":"4"}},{"id":1548658,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF FINANCIAL OFFICER"}}],"security":"Common Stock","published_at":"2024-04-03T21:08:01.000Z","date":"2024-04-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":94,"price":3.08,"value":289.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":131743,"source":{"system":"sec-edgar","filing":"0001415889-24-010074","document":"form4-04032024_090450.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000141588924010074/form4-04032024_090450.xml","form_type":"4"}},{"id":1691028,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2024-01-03T22:22:05.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":62500,"derivative":{"exercise_price":2.33,"expiration_date":"2033-12-31","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001209191-24-000470","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919124000470/doc4.xml","form_type":"4"}},{"id":1691027,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-03T22:22:05.000Z","date":"2024-01-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":93,"price":2.28,"value":212.04,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":131837,"source":{"system":"sec-edgar","filing":"0001209191-24-000470","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919124000470/doc4.xml","form_type":"4"}},{"id":1691026,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2024-01-03T22:22:05.000Z","date":"2024-01-01","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant to the Reporting Person of a restricted stock unit (\"RSU\") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares underlying the RSU vest over a period of 4 years. 25% of the shares subject to the award will vest on March 31, 2025 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":131930,"source":{"system":"sec-edgar","filing":"0001209191-24-000470","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919124000470/doc4.xml","form_type":"4"}},{"id":1708793,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2023-12-15T22:11:27.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest over a period of 4 years. 25% of the shares subject to the option will vest on December 31, 2024 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":62500,"derivative":{"exercise_price":2.7,"expiration_date":"2033-12-12","underlying":"Common Stock","underlying_shares":62500},"source":{"system":"sec-edgar","filing":"0001209191-23-058819","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919123058819/doc4.xml","form_type":"4"}},{"id":1708792,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-12-15T22:11:27.000Z","date":"2023-12-13","kind":"grant","planned":false,"acquired":true,"shares":62500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant to the Reporting Person of a restricted stock unit (\"RSU\") award. Each RSU represents a contingent right to receive one share of common stock of the Issuer."},{"field":"shares","element":"transactionShares","label":"F2","text":"The shares underlying the RSU vest over a period of 4 years. 25% of the shares subject to the award will vest on December 31, 2024 and 6.25% of the shares will vest on the last day of each quarter thereafter. All vesting is subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":69430,"source":{"system":"sec-edgar","filing":"0001209191-23-058819","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919123058819/doc4.xml","form_type":"4"}},{"id":1764933,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-10-04T20:26:12.000Z","date":"2023-10-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":1087,"price":3.83,"value":4163.21,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":6930,"source":{"system":"sec-edgar","filing":"0001209191-23-051960","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919123051960/doc4.xml","form_type":"4"}},{"id":1835233,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-07-05T20:37:12.000Z","date":"2023-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":91,"price":4.1,"value":373.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":8017,"source":{"system":"sec-edgar","filing":"0001209191-23-041139","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919123041139/doc4.xml","form_type":"4"}},{"id":1926873,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-04-04T21:07:05.000Z","date":"2023-03-31","kind":"tax_withholding","planned":false,"acquired":false,"shares":384,"price":3.08,"value":1182.72,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On February 10, 2023, the Issuer effected a one-for-18 reverse split of its Common Stock. The number of securities reported reflects the reverse split."}],"balance_after":8108,"source":{"system":"sec-edgar","filing":"0001209191-23-022806","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919123022806/doc4.xml","form_type":"4"}},{"id":2065849,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Common Stock","published_at":"2023-01-04T22:05:41.000Z","date":"2022-12-31","kind":"tax_withholding","acquired":false,"shares":354,"price":0.15,"value":53.1,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":173005,"source":{"system":"sec-edgar","filing":"0001209191-23-001081","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919123001081/doc4.xml","form_type":"4"}},{"id":2143684,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2022-10-04T21:05:51.000Z","date":"2022-09-30","kind":"tax_withholding","acquired":false,"shares":353,"price":0.223,"value":78.719,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":173359,"source":{"system":"sec-edgar","filing":"0001209191-22-052359","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919122052359/doc4.xml","form_type":"4"}},{"id":2213964,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2022-07-05T21:01:50.000Z","date":"2022-06-30","kind":"tax_withholding","acquired":false,"shares":354,"price":0.389,"value":137.706,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":173712,"source":{"system":"sec-edgar","filing":"0001209191-22-040789","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919122040789/doc4.xml","form_type":"4"}},{"id":2246995,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2022-06-02T20:36:51.000Z","date":"2022-05-31","kind":"grant","acquired":true,"shares":12510,"price":0.3463,"value":4332.213,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Issuer's Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period beginning on December 1, 2021 and ending on May 31, 2022 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's common stock on May 31, 2022 (the last trading day of the offering period)."}],"balance_after":174066,"source":{"system":"sec-edgar","filing":"0001209191-22-033544","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919122033544/doc4.xml","form_type":"4"}},{"id":2307279,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2022-04-04T21:10:16.000Z","date":"2022-03-31","kind":"tax_withholding","acquired":false,"shares":773,"price":0.65,"value":502.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":161556,"source":{"system":"sec-edgar","filing":"0001209191-22-022532","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919122022532/doc4.xml","form_type":"4"}},{"id":2324053,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Stock Options","published_at":"2022-03-18T21:10:31.000Z","date":"2022-03-17","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The awards vest over four years, 25% on March 31, 2023 and 6.25% every three months thereafter, ending on March 31, 2026."}],"balance_after":75000,"derivative":{"exercise_price":0.61,"expiration_date":"2032-03-17","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-22-020067","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919122020067/doc4.xml","form_type":"4"}},{"id":2324052,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CFO"}}],"security":"Common Stock","published_at":"2022-03-18T21:10:31.000Z","date":"2022-03-17","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock unit awards, each of which by its terms represents a contingent right to receive one share of common stock of VYNE Therapeutics Inc."}],"balance_after":162329,"source":{"system":"sec-edgar","filing":"0001209191-22-020067","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919122020067/doc4.xml","form_type":"4"}},{"id":2447517,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Common Stock","published_at":"2022-01-04T21:40:51.000Z","date":"2021-12-31","kind":"tax_withholding","acquired":false,"shares":206,"price":1.02,"value":210.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":87329,"source":{"system":"sec-edgar","filing":"0001209191-22-000861","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919122000861/doc4.xml","form_type":"4"}},{"id":2488154,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Common Stock","published_at":"2021-12-02T22:08:31.000Z","date":"2021-11-30","kind":"grant","acquired":true,"shares":4187,"price":0.8755,"value":3665.7185,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares were acquired under the Issuer's Employee Share Purchase Plan (\"ESPP\") for the ESPP purchase period beginning on June 1, 2021 and ending on November 30, 2021 in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c). In accordance with the terms of the ESPP, these shares were purchased at a price equal to 85% of the fair market value closing price of the Issuer's ordinary shares on November 30, 2021 (the last trading day of the offering period). The reporting person purchased the maximum number of shares permitted by the terms of the ESPP during the calendar year."}],"balance_after":87535,"source":{"system":"sec-edgar","filing":"0001209191-21-067649","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919121067649/doc4.xml","form_type":"4"}},{"id":2553925,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Common Stock","published_at":"2021-10-01T21:12:53.000Z","date":"2021-09-30","kind":"tax_withholding","acquired":false,"shares":206,"price":1.39,"value":286.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":83348,"source":{"system":"sec-edgar","filing":"0001209191-21-058522","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919121058522/doc4.xml","form_type":"4"}},{"id":2578451,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Stock Options","published_at":"2021-09-03T21:35:04.000Z","date":"2021-09-02","kind":"grant","acquired":true,"shares":60860,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"50% of the shares subject to the stock option award will vest on September 30, 2022, and the remaining 50% of the shares will vest thereafter in equal, quarterly installments, subject to the Reporting Person's continued service through the vesting date."}],"balance_after":60860,"derivative":{"exercise_price":1.68,"expiration_date":"2031-09-02","underlying":"Common Stock","underlying_shares":60860},"source":{"system":"sec-edgar","filing":"0001209191-21-054837","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919121054837/doc4.xml","form_type":"4"}},{"id":2578450,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Common Stock","published_at":"2021-09-03T21:35:04.000Z","date":"2021-09-02","kind":"grant","acquired":true,"shares":60859,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents an award of restricted stock units, each of which by its terms represents a contingent right to receive one share of common stock of VYNE Therapeutics Inc. 100% of the awards will vest on September 30, 2023, subject to the Reporting Person's continued service through the vesting date."}],"balance_after":83554,"source":{"system":"sec-edgar","filing":"0001209191-21-054837","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919121054837/doc4.xml","form_type":"4"}},{"id":2643668,"issuer":{"id":6871,"kind":"organization","name":"Yarrow Bioscience, Inc."},"owners":[{"id":27990,"kind":"person","name":"Zeronda Tyler","position":1,"cik":"0001867033","reported_name":"Zeronda Tyler","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Interim CFO"}}],"security":"Common Stock","published_at":"2021-07-02T20:37:31.000Z","date":"2021-06-30","kind":"tax_withholding","acquired":false,"shares":700,"price":3.51,"value":2457.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares that have been withheld by the Issuer to satisfy tax withholding requirements in connection with the vesting of restricted stock units."}],"balance_after":22695,"source":{"system":"sec-edgar","filing":"0001209191-21-044983","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1566044/000120919121044983/doc4.xml","form_type":"4"}}]}